-
公开(公告)号:CA385180A
公开(公告)日:1939-11-21
申请号:CA385180D
Applicant: STEWART DUNCAN J
Inventor: STEWART DUNCAN J
-
公开(公告)号:AU2003294541A1
公开(公告)日:2004-07-22
申请号:AU2003294541
申请日:2003-12-24
Applicant: STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ , AN GO GEN INC
Inventor: STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
-
公开(公告)号:CA385179A
公开(公告)日:1939-11-21
申请号:CA385179D
Applicant: STEWART DUNCAN J
Inventor: STEWART DUNCAN J
-
公开(公告)号:AU2003294540A1
公开(公告)日:2004-07-22
申请号:AU2003294540
申请日:2003-12-24
Applicant: COURTMAN DAVID , NORTHERN THERAPEUTICS INC , STEWART DUNCAN J , BABAEI SAEID
Inventor: COURTMAN DAVID , STEWART DUNCAN J , BABAEI SAEID
IPC: A61K31/198 , A61K31/216 , A61K38/17 , A61K38/18 , A61K48/00 , C12N9/02
Abstract: Early onset of pulmonary disorders such as pulmonary hypertension are treated or prevented by administration of an apoptosis inhibitor or a survival factor. Early onset of such disorders may be diagnosed by assessing apoptosis in lung tissue.
-
公开(公告)号:WO2004058305A2
公开(公告)日:2004-07-15
申请号:PCT/CA0302008
申请日:2003-12-24
Applicant: AN GO GEN INC , STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
Inventor: STEWART DUNCAN J , COURTMAN DAVID , KAROUBI GOLNAZ
CPC classification number: A61K9/5036 , A61K35/12 , C12N5/0656 , C12N5/0663 , C12N11/04 , C12N2533/52 , C12N2533/56 , C12N2533/76
Abstract: Cell therapy comprises encapsulating a cell with an integrin or other cell interaction factor, for administration to a mammal. The cells may express a therapeutic transgene or the cells may be regenerative.
Abstract translation: 细胞疗法包括用整联蛋白或其它细胞相互作用因子包封细胞,用于给予哺乳动物。 细胞可以表达治疗性转基因,或细胞可以是再生的。
-
公开(公告)号:US2549030A
公开(公告)日:1951-04-17
申请号:US77011447
申请日:1947-08-22
Applicant: STEWART DUNCAN J
Inventor: STEWART DUNCAN J
IPC: F41G5/08
CPC classification number: F41G5/08
-
-
-
-
-